Although emerging evidence suggests that the AA genotype may be associated with poorer prognosis in hormone-independent BC [9], no statistically significant differences in OS were observed across HSD3B1 genotypes in our TNBC cohort (Figure 1). The gene discussed is HSD3B1; the disease is breast cancer.